Dr. Wendy F Aita, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1474 Tanyard Road, Suite C100, Sewell, NJ 08080 Phone: 856-932-7476 Fax: 856-566-6320 |
Dr. Shari Welsh, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 123 Egg Harbor Rd Ste 302, Sewell, NJ 08080 Phone: 609-634-6835 |
Dr. Bryan Hendricks, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 123 Egg Harbor Rd., Suite 302, Sewell, NJ 08080 Phone: 856-952-6494 |
Dr. Troy Heckert, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 225 Salem Ave, Sewell, NJ 08080 Phone: 267-307-1006 |
News Archive
Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.
The Critical Path Institute and Provention Bio, Inc. are proud to announce their collaboration to significantly improve the scientific community's insight into type 1 diabetes through Provention's contribution of data from the Phase III Protégé study of teplizumab to the T1D Trial Outcome Measures Initiative integrated database.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.
Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.
› Verified 4 days ago